Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
Share This Page

EGF and TGF-α motogenic activities are mediated by the EGF receptor: Identification of signaling pathways involved in oral cancer

International Conference on Cancer Epigenetics and Biomarkers
October 26-28, 2017 Osaka, Japan

Aye Myat Thwe

University of Dundee, UK

Posters & Accepted Abstracts: Arch Can Res

Abstract:

Epithelial to mesenchymal transition (EMT) is the process by which cells change shape from being tightly connected epithelial cells to more motile mesenchymal cell. EMT has been reported to facilitate cell migration. Cell motility is an initial first step on the road to metastasis. Epidermal growth factor receptor (EGFR) has been reported to be overexpressed in oral cancer and is often related with poor prognosis. Epidermal growth factor (EGF) and transforming growth factor (TGF-�±) are ligands that bind to EGFR and can affect many different cellular process such as proliferation, migration, apoptosis, etc. In this project, cell proliferation, migration, morphology change and EMT makers of HSG, AZA1, HacaT and TYS are measured by cell counting, scratch assay, photographic image capturing and immunofluorescence in related with addition of 1 ng/ml, 10 ng/ml, 50 ng/ml of EGF and TGF�± incubated at different time point. 10 ng/ml and 50 ng/ml concentration induce morphology change (EMT like phenotype with finger like projection) and increase migration while there is not much difference in cell proliferation. Their morphological changes are completely blocked by 1-hour pre-treatment with 5 �µM Gefitinib (EGFR tyrosine kinase inhibitor), 5 �µM Erlotinib (EGFR TK inhibitor) and 25 �µM PD (MAPK inhibitor) while there is no blockage of cell migration.